Change in substantial holding
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- Notice of Annual General Meeting/Proxy Form
- Change of Director's Interest Notice - C Maley
- Application for quotation of securities - SPL
- Notification of cessation of securities - SPL
- Chair and Deputy Chair Appointments
Later from Starpharma
- Trading Halt
- Starpharma secures majority ownership of Petalion
- Starpharma Investor Presentation Petalion Webinar
- $3.5 Million R&D Tax Incentive Received
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma